Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI164710
National Institutes of Health
Grant: R01AI138495
NIDDK NIH HHS
Grant: U2C DK129500
NIGMS NIH HHS
Grant: R25 GM089614
NIDDK NIH HHS
Grant: TL1 DK132771
National Institutes of Health
Grant: 5R01AI138495-02
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
National Institutes of Health
Grant: 5R01AI164710-04
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
FWCI
1.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals